General Information of Disease (ID: DISCT4GX)

Disease Name Hemoglobinopathy
Synonyms globin abnormality; hemoglobin disease; haemoglobin disease; haemoglobin disorder; hemoglobin disorder; hemoglobinopathy
Disease Hierarchy
DISWD40R: Disease
DISDMSC5: Erythrocyte disorder
DISCT4GX: Hemoglobinopathy
Disease Identifiers
MONDO ID
MONDO_0044348
MESH ID
D006453
UMLS CUI
C0019045
MedGen ID
42400
SNOMED CT ID
80141007

Drug-Interaction Atlas (DIA) of This Disease

Drug-Interaction Atlas (DIA)
This Disease is Treated as An Indication in 1 Approved Drug(s)
Drug Name Drug ID Highest Status Drug Type REF
Pegfilgrastim DM7UP8X Approved Small molecular drug [1]
------------------------------------------------------------------------------------

Molecular Interaction Atlas (MIA) of This Disease

Molecular Interaction Atlas (MIA)
This Disease Is Related to 4 DTT Molecule(s)
Gene Name DTT ID Evidence Level Mode of Inheritance REF
BCL11A TTR61MW Limited Altered Expression [2]
EIF2AK1 TTRUJBV Limited Biomarker [3]
HBA2 TTQO71U moderate Genetic Variation [4]
HBB TTM6HK1 Strong Genetic Variation [5]
------------------------------------------------------------------------------------
This Disease Is Related to 1 DME Molecule(s)
Gene Name DME ID Evidence Level Mode of Inheritance REF
ALAS2 DE437BY Limited Genetic Variation [6]
------------------------------------------------------------------------------------
This Disease Is Related to 14 DOT Molecule(s)
Gene Name DOT ID Evidence Level Mode of Inheritance REF
AADAC OT8VACT2 Limited Biomarker [7]
EVA1C OT18YR25 Limited Biomarker [8]
FBXW4 OTEGSZOX Limited Biomarker [7]
FUT1 OTODG57A Limited Genetic Variation [9]
HBZ OTMHGFSS Limited Biomarker [10]
HUNK OTZR4GBH Limited Biomarker [8]
RHBDF1 OTCQ7UDS Limited Genetic Variation [11]
KLF1 OT1FK08U Disputed Genetic Variation [12]
HBA1 OTW2BQF4 moderate Genetic Variation [4]
HBG1 OTVL4NSU moderate Altered Expression [13]
GYPB OTESHUIX Strong Genetic Variation [14]
GYPE OTBHAG6A Strong Genetic Variation [14]
HBD OTRQG4WA Strong Genetic Variation [15]
HBG2 OT4J48JJ Strong Genetic Variation [16]
------------------------------------------------------------------------------------
⏷ Show the Full List of 14 DOT(s)

References

1 A standard database for drug repositioning. Sci Data. 2017 Mar 14;4:170029.
2 Genome-wide association study shows BCL11A associated with persistent fetal hemoglobin and amelioration of the phenotype of beta-thalassemia.Proc Natl Acad Sci U S A. 2008 Feb 5;105(5):1620-5. doi: 10.1073/pnas.0711566105. Epub 2008 Feb 1.
3 Domain-focused CRISPR screen identifies HRI as a fetal hemoglobin regulator in human erythroid cells.Science. 2018 Jul 20;361(6399):285-290. doi: 10.1126/science.aao0932.
4 Atypical Prenatal Ultrasound Presentation and Neuropathological Findings in a Neonate With Alpha Thalassemia Major: A Case Report.Pediatr Dev Pathol. 2019 Mar-Apr;22(2):166-170. doi: 10.1177/1093526618817655. Epub 2018 Dec 14.
5 Synergistic Effect of Simvastatin and Romidepsin on Gamma-globin Gene Induction.Cell J. 2019 Jan;20(4):576-583. doi: 10.22074/cellj.2019.5589. Epub 2018 Aug 1.
6 Iron overload in an African American woman with SS hemoglobinopathy and a promoter mutation in the X-linked erythroid-specific 5-aminolevulinate synthase (ALAS2) gene.Blood Cells Mol Dis. 2005 May-Jun;34(3):226-8. doi: 10.1016/j.bcmd.2005.01.001.
7 In vivo effects of decitabine in myelodysplasia and acute myeloid leukemia: review of cytogenetic and molecular studies.Ann Hematol. 2005 Dec;84 Suppl 1:32-8. doi: 10.1007/s00277-005-0004-1.
8 Persistent B19 infection in immunocompetent individuals: implications for transfusion safety.Blood. 2005 Oct 15;106(8):2890-5. doi: 10.1182/blood-2005-03-1053. Epub 2005 Jun 23.
9 High-Efficiency Lentiviral Transduction of Human CD34(+) Cells in High-Density Culture with Poloxamer and Prostaglandin E2.Mol Ther Methods Clin Dev. 2019 Jan 25;13:187-196. doi: 10.1016/j.omtm.2019.01.005. eCollection 2019 Jun 14.
10 Screening of (-SEA) -thalassaemia using an immunochromatographic strip assay for the -globin chain in a population with a high prevalence and heterogeneity of haemoglobinopathies.J Clin Pathol. 2017 Jan;70(1):63-68. doi: 10.1136/jclinpath-2016-203765. Epub 2016 Jun 16.
11 Construction and expression of a recombinant adeno-associated virus that harbors a human beta-globin-encoding cDNA.Gene. 1991 Aug 15;104(2):253-7. doi: 10.1016/0378-1119(91)90258-d.
12 Differential role of Kruppel like factor 1 (KLF1) gene in red blood cell disorders.Genomics. 2019 Dec;111(6):1771-1776. doi: 10.1016/j.ygeno.2018.11.032. Epub 2018 Dec 5.
13 The effect of histone deacetylase inhibitors on AHSP expression.PLoS One. 2018 Feb 1;13(2):e0189267. doi: 10.1371/journal.pone.0189267. eCollection 2018.
14 DNA array analysis for red blood cell antigens facilitates the transfusion support with antigen-matched blood in patients with sickle cell disease.Vox Sang. 2009 Aug;97(2):147-52. doi: 10.1111/j.1423-0410.2009.01185.x. Epub 2009 Apr 8.
15 Delta globin gene variations leading to reduction in HbA(2) levels.Int J Lab Hematol. 2016 Dec;38(6):610-615. doi: 10.1111/ijlh.12548. Epub 2016 Jul 27.
16 Characterization of deletional and non-deletional alpha globin variants in a large cohort from Spain between 2009 and 2014.Ann Hematol. 2019 Jul;98(7):1537-1545. doi: 10.1007/s00277-019-03696-w. Epub 2019 Apr 25.